Apr 12, 2021
Reducing health disparities by examining the effectiveness of tools that encourage end-of-life conversations may improve the likelihood that underserved patients receive care that is consistent with their values and beliefs
Apr 8, 2021
Read a roundup of announcements and short articles for the week of April 5.
Penn State Health asks its health care professionals to understand the importance of supporting our Muslim patients who observe Ramadan, which is April 12 to May 12.
Hershey Medical Center President Deborah Berini and members of the executive team will hold virtual town hall meetings every other month, beginning April 29.
A Penn State Health team is evaluating the health system’s ability to translate and interpret for its non-English-speaking patients with an eye toward making improvements. Employees and faculty can help by completing a ten-question survey, by Friday, April 30.
Psychiatry and Behavioral Health staff at Penn State Health put aside their own anxiety and uncertainty to offer reassurance to patients, colleagues and community members during the past year.
Apr 7, 2021
For months now, we’ve been hearing about how the COVID-19 vaccines show promise of finally moving past the pandemic. But now comes word that the virus that causes COVID is mutating. In this interview, we learn what this process means for the pandemic that has lasted for over a year now. Are the mutations another roadblock to getting our lives back to normal? We get answers from two Penn State Health experts.
For a small group of COVID-19 survivors, often referred to as “long haulers,” fatigue, shortness of breath, dizziness, gastrointestinal symptoms, anxiety and depression can persist for months and can range from mild to incapacitating.
Penn State Clinical and Translational Science Institute’s Early-Stage Investigator Training Program welcomes Chris Sciamanna, MD, to its leadership team.
El distanciamiento social y el aislamiento pueden haber reducido la propagación del COVID-19, pero los investigadores de la Facultad de Medicina de Penn State Health informan que esas acciones pueden haber afectado la capacidad de los investigadores clínicos para terminar los ensayos.
